Theragen Etex Co.,Ltd. announced that it has received KRW 10.65 billion in funding

THERAGEN ETEX CO.LTD. is a Korea-based company engaged in the industrial equipment business, healthcare and genome business and pharmaceutical business. The Company operates its business through three divisions: flat panel display (FPD) manufacturing equipment division, which provides loading and unloading systems, printed circuit board (PCB) bonding systems, battery washing lines and laser systems; healthcare and genome division engages in the provision of genome analysis services and others, and pharmaceutical division engages in the manufacture of digestive system remedies, antibiotics, remedies for fever, circulatory system remedies, respiration system remedies, treatment for chronic hepatitis, diabetes remedies, psychotropic agents, osteoporosis treatments and others.